Skip to main content
. 2020 Sep 23;11(9):790. doi: 10.1038/s41419-020-03009-4

Fig. 5. DEX treatment modulates drug sensitivities in OC cell lines and PDC.

Fig. 5

a Plots depicting drug-sensitivity scores (DSS) for OC cell lines and PDCs representing Ctrl (untreated) vs. DEX-treated cells. Selected SMAC mimetic drugs and paclitaxel are highlighted in red. bd Hierarchically clustered heatmaps for ΔDSS (DSSDex – DSSCtrl) values for selected kinase inhibitors (b), conventional chemotherapy drugs (c), and apoptotic modulators (d).